경구 bisphosphonate를 복용하는 환자에서 발생한 bisphosphonate-related osteonecrosis of jaw에 대한 임상적 특징 및 처치: 증례보고
Clinical feature and treatment of bisphosphonate-related osteonecrosis of jaw about oral bisphosphonate administrated patients: case reports
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Bisphosphonates are used effectively for many medical conditions, such as multiple myeloma, Paget’s disease, osteoporosis, etc. However, recently,osteonecrosis of the jaw was observed in patients receiving long-term bisphosphonate therapy, including oral administration. This osteonecrosis is refractory, and complete recovery is not guaranteed despite a standard treatment protocol being established by many associations related to oral and maxillofacial surgery. The treatment outcome of oral bisphosphonate-related osteonecrosis of jaw (BRONJ) is reported with a review of the relevant literature
Abstract
Bisphosphonates are used effectively for many medical conditions, such as multiple myeloma, Paget’s disease, osteoporosis, etc. However, recently,osteonecrosis of the jaw was observed in patients receiving long-term bisphosphonate therapy, including oral administration. This osteonecrosis is refractory, and complete recovery is not guaranteed despite a standard treatment protocol being established by many associations related to oral and maxillofacial surgery. The treatment outcome of oral bisphosphonate-related osteonecrosis of jaw (BRONJ) is reported with a review of the relevant literature
참고문헌 (22)
- Ashcroft AJ, "Aetiology of bone disease and the role of bisphosphonates in multiple myeloma", Lancet Oncol, 4, pp.284~292 (2003)
- Delmas PD, "The management of Paget’s disease of bone", N Engl J Med, 336, pp.558~566 (1997)
- Hillner BE, "American Society of Clinical Oncology. American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer", J Clin Oncol, 21, pp.4042~4057 (2003)
- Olson KB, "Osteonecrosis of jaw in patient with hormone-refractory prostate cancer treated with zoledronic acid", Urology, 66, pp.658~ (2005)
- Rosen LS, "Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, Phase III, double-blind, placebo-controlled trial", Cancer, 100, pp.2613~2621 (2004)
- Boonyapakorn T, "Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies", Oral Oncol, 44, pp.857~869 (2008)
- Fleisch H, "Bisphosphonates in osteoporosis", Eur Spine J, 12(2), pp.142~146 (2003)
- Letocha AD, "Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement", J Bone Miner Res, 20, pp.977~986 (2005)
- Ruggiero SL, "American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws-2009 Update", J Oral Maxillofac Surg, 67(5), pp.2~12 (2009)
- Carlson ER, "The role of surgical resection in the management of bisphosphonate-belated osteonecrosis of the jaws", J Oral Maxillofac Surg, 67(5), pp.85~95 (2009)
- Williamson RA, "Surgical management of bisphosphonate induced osteonecrosis of the jaws", Int J Oral Maxillofac Surg, 39, pp.251~255 (2010)
- Marx RE, "Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic", J Oral Maxillofac Surg, 61, pp.1115~1117 (2003)
- Ruggiero SL, "Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases", J Oral Maxillofac Surg, 62, pp.527~534 (2004)
- Ruggiero SL, "Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 102, pp.433~441 (2006)
- Marx RE, "Bisphosphonateinduced exposed bone (osteonecrosis", osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment, 2005, pp.63, 1567~1575
- review: bisphosphonates and osteonecrosis of the jaws, "Ann Intern Med", 2006, 753~761
- Chaudhry AN, "Osteonecrosis and bisphosphonates in oral and maxillofacial surgery", Oral Maxillofacial Surg Clin North Am, 19, pp.199~206 (2007)
- Badros A, "Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors", J Clin Oncol, 24, pp.945~952 (2006)
- Mavrokokki T, "Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia", J Oral Maxillofac Surg, 65, pp.415~423 (2007)
- "J Oral Maxillofac Surg", 2007, 573~580
- Adornato M, "The treatment of bisphosphonate- associated osteonecrosis of the jaws with bone resection and autogenous platelet-derived growth factors", J Am Dent Assoc, 138, pp.971~977 (2007)
- Freiberger JJ, "Utility of hyperbaric oxygen in treatment of bisphosphonate related osteonecrosis of the jaws", J Oral Maxillofac Surg, 67(5), pp.96~106 (2009)